Drs Kathy D. Miller and Sunil S. Badve discuss the importance of identifying HER2-low patients, those with ultra-low staining, and the benefit of targeted ADCs. Relevant disclosures can be found with the episode show notes on Medscape...
Subscribe to your favorite podcasts and get free AI summaries within minutes of release.
Browse trending podcasts or search for your favorites
One click to follow any show — always free, no credit card
Free AI summaries delivered by email within minutes of release
Free forever · No credit card · Unsubscribe anytime
Never miss an episode of Medscape InDiscussion: Breast Cancer and HER2. Subscribe for free →
No transcript available.
